CureVac names former Cardior CFO Axel Sven Malkomes as new CFO
CVAC Stock | USD 3.90 0.38 8.88% |
About 52% of CureVac NV's investor base is interested to short. The analysis of the overall investor sentiment regarding CureVac NV suggests that many traders are impartial. The current market sentiment, together with CureVac NV's historical and current headlines, can help investors time the market. In addition, many technical investors use CureVac NV stock news signals to limit their universe of possible portfolio assets.
CureVac said it has appointed Axel Sven Malkomes. the former CFO of Cardior Pharmaceuticals, as its new chief financial officer, effective Nov. 11. Read more here.
Read at seekingalpha.com
![]() |
CureVac NV Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards CureVac NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
CureVac NV Fundamental Analysis
We analyze CureVac NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CureVac NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CureVac NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
CureVac NV is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
CureVac NV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CureVac NV stock to make a market-neutral strategy. Peer analysis of CureVac NV could also be used in its relative valuation, which is a method of valuing CureVac NV by comparing valuation metrics with similar companies.
Peers
CureVac NV Related Equities
MRRTY | Marfrig Global | 2.86 | ||||
ALFDF | Astral Foods | 0.00 | ||||
K | Kellanova | 0.33 | ||||
ABEV | Ambev SA | 0.40 | ||||
GFL | Gfl Environmental | 0.42 | ||||
LWAY | Lifeway Foods | 0.62 | ||||
CECO | CECO Environmental | 1.98 | ||||
BLSFY | BlueScope Steel | 2.29 |
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |